An immunohistochemical study evaluating the expression of IGFs, IGF-1R, and IGFBPs in the lungs of patients with LAM found that only a proportion of patients have IGF-1 expression in LAM cells while reaction for IGF-2 was detected in almost every patient enrolled (40). Here, IGF1 is linked to lymphangioleiomyomatosis.